Article

B + L expands recall

Bausch + Lomb (B + L) has expanded its voluntary recall of methylcellulose lubricant ophthalmic solution, USP 1% (Murocel) to six lots. Following this voluntary product recall, B + L will discontinue the product entirely.

Madison, NJ-Bausch + Lomb (B + L) has expanded its voluntary recall of methylcellulose lubricant ophthalmic solution, USP 1% (Murocel) to six lots. Following this voluntary product recall, B + L will discontinue the product entirely.

This voluntary recall and product discontinuation is an expansion of the voluntary recall of a single lot of the solution that B + L initiated July 6.

According to B + L, the company chose to initiate this six-lot recall in the interest of patient safety after routine stability testing revealed that the lots were out of specification for preservative efficacy. No adverse events have been reported that have been attributed to the product lots being out of specification for preservative efficacy.

The recall is limited only to the United States; it does not affect locations in Europe, the Middle East, or Asia-Pacific regions. Expiry dates of the affected products are Sept. 30, 2011, through Jan. 31, 2013.

In addition to asking consumers to return the affected products to the company, B + L has directly contacted U.S. retailers that have been shipped this product to initiate the recall and inform them of the steps they should take to return the product. B + L also has contacted eye-care professionals to alert them of the recall.

B + L said it has chosen to discontinue the methylcellulose lubricant ophthalmic solution because it has products within its portfolio to treat the same symptoms for which the solution is indicated.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
John Tan talks about an emergency triage framework for retinal artery occlusion at the 2025 Association for Research in Vision and Ophthalmology (ARVO) meeting.
Dr Robert Maloney at the 2025 Controversies in Modern Eye Care meeting
Wendy Lee, MD, MS, at Controversies in Modern Eye Care 2025.
I. Paul Singh, MD, speaks about glaucoma treatment and successful ophthalmic / optometric comanagement at the 19th Annual Controversies in Modern Eye Care meeting
(Image credit: Ophthalmology Times)  ASCRS 2025: Joaquin De Rojas, MD, leverages machine learning model to predict arcuate outcomes
(Image credit: Ophthalmology Times) ASCRS 2025: AnnMarie Hipsley, DPT, PhD, presents VESA for biomechanical simulation of presbyopia progression
Shehzad Batliwala, DO, aka Dr. Shehz, discussed humanitarian ophthalmology and performing refractive surgery in low-resource, high-risk areas at the ASCRS Foundation Symposium.
© 2025 MJH Life Sciences

All rights reserved.